文献速递腹部介入CT

量化CT引导经皮热消融后功能性肝体积损失:COVER-ALL试验事后分析

Quantifying Functional Liver Volume Loss after CT-guided Percutaneous Thermal Ablation: A COVER-ALL Trial Post Hoc Analysis.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

基于COVER-ALL单中心随机对照试验的事后分析,比较软件消融确认与视觉边缘评估两组患者CT测得的功能性肝体积损失与最小消融边缘。结果显示,软件消融确认组最小消融边缘更大,功能性肝体积损失百分比虽较高但增幅可忽略,且功能性肝体积损失百分比与血清白蛋白或总胆红素变化无关联。

要点

  • 肝肿瘤热消融后功能性肝体积损失百分比较小。
  • 软件消融确认组最小消融边缘大于视觉评估组,功能性肝体积损失百分比仅轻微增加。
  • 功能性肝体积损失百分比与血清白蛋白或总胆红素变化无显著关联。

核心结论

  • 肝肿瘤热消融导致的功能性肝体积损失百分比较小;使用软件消融确认增加了最小消融边缘,代价是功能性肝体积损失百分比出现可忽略的增加。

研究设计与样本

  • COVER-ALL单中心随机对照试验(2020年6月至2023年10月)的事后分析,纳入100例组织学不限的肝肿瘤患者,实验组74例(消融98个肿瘤,中位直径1.5 cm),对照组26例(消融41个肿瘤,中位直径1.3 cm),比较CT衍生体积、最小消融边缘及基于实验室的肝功能变化。

诊断标准与关键数值

  • 实验组与对照组基线中位功能性肝体积分别为1707 cm3(IQR,1467-1964 cm3)与1722 cm3(IQR,1338-1916 cm3),P=0.84;实验组中位最小消融边缘为6 mm(IQR,4.5-7.9 mm),大于对照组的1 mm(IQR,0-4 mm),P<0.001;实验组中位功能性肝体积损失百分比为2.9%(IQR,1.8%-4.4%),大于对照组的1.7%(IQR,1.2%-3.4%),P=0.03;消融后中位功能性肝体积实验组为1643 cm3(IQR,1403-1886 cm3),对照组为1696 cm3(IQR,1315-1843 cm3),P=0.87。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To quantify functional liver volume (FLV) loss relative to minimal ablative margins (MAMs) achieved during percutaneous thermal ablation (TA) of liver tumors in COVER-ALL randomized controlled trial (RCT) participants. Materials and Methods In the COVER-ALL single-center RCT (June 2020 through October 2023), software-based ablation confirmation (AC) (experimental) and visual margin (control) assessment were compared among participants with histology-agnostic liver tumors. In this post hoc analysis, the authors compared CT-derived volumes, MAMs, and changes in laboratory-based hepatic function using Wilcoxon rank sum and Spearman correlation tests. Results Among 100 participants (mean age ± SD, 57.8 years ± 13.2; 61 male; experimental group, n = 74, 98 tumors ablated, median diameter = 1.5 cm; control group, n = 26, 41 tumors ablated, median diameter = 1.3 cm), the experimental and control group baseline median FLVs (1707 cm3 [IQR, 1467-1964 cm3] vs 1722 cm3 [IQR, 1338-1916 cm3]; P = .84) were comparable. The median MAM was larger in the experimental versus the control group (6 mm [IQR, 4.5-7.9 mm] vs 1 mm [IQR, 0-4 mm]; P < .001). The median percentage FLV loss was larger in the experimental versus the control group (2.9% [IQR, 1.8%-4.4%] vs 1.7% [IQR, 1.2%-3.4%]; P = .03). The median postablation FLV was comparable between the experimental and control groups (1643 cm3 [IQR, 1403-1886 cm3] and 1696 cm3 [IQR, 1315-1843 cm3]; P = .87). We observed no association between percentage FLV loss and changes in serum albumin (ρ = -0.153, P = .16) or total bilirubin concentrations (ρ = -0.128, P = .25). Conclusion Liver tumor TA resulted in minimal percentage FLV loss. Software-based AC use increased the MAM at the expense of a negligible increase in percentage FLV loss. Keywords: Ablation Techniques, Segmentation, Liver, Volume Analysis ClinicalTrials.gov: NCT04083378 Supplemental material is available online. © RSNA, 2026.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Siddiqi NS, Albuquerque J, Paolucci I, et al. Quantifying Functional Liver Volume Loss after CT-guided Percutaneous Thermal Ablation: A COVER-ALL Trial Post Hoc Analysis. Radiol Imaging Cancer. 2026. PMID: 41823606. doi:10.1148/rycan.250385

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。